Needham Reiterates Hold Rating on Medtronic, Inc. (MDT)
Needham analyst Michael Matson reiterated a Hold rating on Medtronic, Inc. (NYSE: MDT).
The analyst comments "Medtronic (MDT - Hold) will report its F1Q26 earnings on Tuesday, 8/19/25 at 6:45 am ET and host its earnings webcast at 8:00 am ET. Inside this note, we provide a preview of its earnings report including our expectations for its F1Q26 results, management's FY26 guidance update, and topics we expect to be discussed on the call. We expect MDT to beat consensus revenue and EPS in F1Q26 given new product launches, healthy market growth, favorable currency movements, and management's conservative guidance. And we expect MDT to raise its FY26 revenue and EPS guidance given F1Q26 upside, favorable currency, and tariff reductions/mitigation. We believe that MDT is in the early stages of a strong product cycle lead by its Affera PFA system, Symplicity RDN system, Simplera Sync CGM, and Hugo robot, but we maintain our Hold rating until there are signs that its organic growth is seeing meaningful, and sustainable, acceleration."
For an analyst ratings summary and ratings history on Medtronic, Inc. click here. For more ratings news on Medtronic, Inc. click here.
Shares of Medtronic, Inc. closed at $91.98 yesterday.